Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of PF-06952229 in adults with advanced solid tumors was terminated. Results were posted on 2024-06-26.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma [Phase 1]
A Phase 1 study evaluating abemaciclib in combination with sunitinib for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AK112 as monotherapy in advanced or metastatic renal cell carcinoma, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study examining trans-arterial/intra-tumor infusion of checkpoint inhibitors plus chemotherapy f…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma [Phase 3]
Phase 3 trial evaluating systemic therapy alone versus systemic therapy plus radiotherapy for oligometastatic renal cell carcinoma is curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Novel Prognostic Markers in Renal Cancer
This clinical trial update summarizes findings from a completed study investigating novel prognostic markers in renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) [Phase 1]
This document describes a Phase 1 dose-escalation trial of PT2385 in patients with advanced clear cell renal cell carcinoma (renal cell carc…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial update for ADCT-301 (camidanlumab tesirine) in selected advanced solid tumors; the study has been terminated and results have …
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Study to Compare Two Partial Nephrectomy Techniques for Renal Tumors: Robot-assisted vs Videolaparoscopic [NA]
This clinical trial update describes a study comparing robot-assisted versus videolaparoscopic partial nephrectomy techniques for renal tumo…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors. [NA]
A clinical trial comparing laparoscopic versus robotic partial nephrectomy for renal tumors, currently recruiting and not reporting results.
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer [Phase 1]
Phase 1 trial evaluating CBM588 capsules in combination with nivolumab and ipilimumab for advanced or metastatic renal cell carcinoma, inclu…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer [NA]
A trial evaluating stereotactic body radiation therapy for metastatic or recurrent renal cell carcinoma was terminated; results were posted …
-
CLINICAL_TRIALS safety_alert · 2024-05-29Clinical Trial Update: Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
This post-marketing surveillance update assesses the safety of Cabometyx in Korean patients with Renal Cell Carcinoma, Hepatocellular Carcin…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of immunotherapy combinations across multiple advanced cancers and has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau [Phase 2]
A Phase 2 trial assessing contrast-enhanced ultrasound for screening kidney cancer in patients with Von Hippel-Lindau disease has completed,…
-
FDA label_change · 2024-05-20FDA Approved: PAZOPANIB — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for pazopanib by Apotex Corp. (ANDA 217713), likely involving labeling or other post-approval change…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 multi-center trial of ESK981 in combination with nivolumab for metastatic renal cell carcinoma was terminated, and results were po…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with stereotactic ablative radiotherapy for metastatic colorectal cancer, non-…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma [Phase 2]
Phase 2 trial investigating neoadjuvant pembrolizumab with stereotactic radiotherapy before nephrectomy in renal cell carcinoma; currently r…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
Pfizer-sponsored real-world study assesses patterns of care and outcomes in AfME patients with metastatic renal cell carcinoma treated with …
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)
The SABINA trial is evaluating stereotactic body radiotherapy for medically inoperable localized renal tumors. It is currently active but no…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 [Phase 1]
A first-in-human Phase 1 trial of BMC128 in combination therapy evaluating a single dose level, across multiple cancers; status is active bu…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
This clinical trial update reports the completion of studies examining biomarkers of angiogenesis in renal cell carcinoma and neuroendocrine…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: VEGF Imaging in Renal Cell Carcinoma
A clinical trial sponsored by University Medical Center Groningen evaluating VEGF imaging in renal cell carcinoma has completed.